Vascular effects of dietary L-arginine supplementation - PubMed (original) (raw)
Review
Vascular effects of dietary L-arginine supplementation
Robert B Preli et al. Atherosclerosis. 2002 May.
Abstract
The vascular endothelium is acknowledged to play an important role in vascular physiology. Attention has focused on endothelial production of nitric oxide as a key element in many of the processes associated with the development of atherosclerosis. L-arginine is the substrate for the enzyme nitric oxide synthase (NOS), which is responsible for the endothelial production of nitric oxide. Therefore, many investigators have been interested in whether dietary L-arginine supplementation can augment nitric oxide production and thereby improve vascular health. The effects of oral L-arginine on vascular health and disease have been examined both in human beings and in various animal models. In this review, we summarize the results of studies of oral L-arginine supplementation on atherosclerotic lesion formation, as well as markers of endothelial function (e.g. macrophage function, platelet aggregation and adhesion, and in vitro vascular ring studies). Although results of oral L-arginine supplementation in hypercholesterolemic animals have generally shown beneficial effects, the data in humans are varied, possibly because of small sample sizes and brief periods of study. Long-term randomized clinical trials are needed to more definitively address whether oral L-arginine supplementation could be advantageous for vascular health.
Similar articles
- Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Adams MR, et al. J Am Coll Cardiol. 1995 Oct;26(4):1054-61. doi: 10.1016/0735-1097(95)00257-9. J Am Coll Cardiol. 1995. PMID: 7560599 Clinical Trial. - Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D, Böger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Tousoulis D, et al. Nat Clin Pract Cardiovasc Med. 2007 May;4(5):274-83. doi: 10.1038/ncpcardio0878. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17457351 Review. - Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.
Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Adams MR, et al. Atherosclerosis. 1997 Mar 21;129(2):261-9. doi: 10.1016/s0021-9150(96)06044-3. Atherosclerosis. 1997. PMID: 9105569 Clinical Trial. - [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM. Bode-Böger SM. Dtsch Med Wochenschr. 2005 Mar 18;130(11):593-8. doi: 10.1055/s-2005-865070. Dtsch Med Wochenschr. 2005. PMID: 15761791 Review. German. - Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys.
Dhawan V, Handu SS, Nain CK, Ganguly NK. Dhawan V, et al. Mol Cell Biochem. 2005 Jan;269(1-2):1-11. doi: 10.1007/s11010-005-1810-4. Mol Cell Biochem. 2005. PMID: 15786711
Cited by
- Combined antihypertensive effect of unripe Rubus coreanus Miq. and Dendropanax morbiferus H. Lév. Extracts in 1 kidney-1 clip hypertensive rats and spontaneously hypertensive rats.
Park S, Lee KH, Choi H, Jang G, Kang WS, Kim E, Kim JS, Na CS, Kim S. Park S, et al. BMC Complement Med Ther. 2021 Oct 28;21(1):271. doi: 10.1186/s12906-021-03438-4. BMC Complement Med Ther. 2021. PMID: 34711215 Free PMC article. - L-Arginine supplementation does not enhance blood flow and muscle performance in healthy and physically active older women.
Aguiar AF, Balvedi MC, Buzzachera CF, Altimari LR, Lozovoy MA, Bigliassi M, Januário RS, Pereira RM, Sanches VC, da Silva DK, Muraoka GA. Aguiar AF, et al. Eur J Nutr. 2016 Sep;55(6):2053-62. doi: 10.1007/s00394-015-1019-6. Epub 2015 Aug 18. Eur J Nutr. 2016. PMID: 26280946 Clinical Trial. - Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
Czarnecka A, Milewski K, Zielińska M. Czarnecka A, et al. Neurochem Res. 2017 Mar;42(3):750-761. doi: 10.1007/s11064-016-2111-x. Epub 2016 Nov 25. Neurochem Res. 2017. PMID: 27885576 Free PMC article. Review. - Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ, Chew GT, Watts GF. Woodman RJ, et al. Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review. - Treating coronary disease and the impact of endothelial dysfunction.
Matsuzawa Y, Guddeti RR, Kwon TG, Lerman LO, Lerman A. Matsuzawa Y, et al. Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):431-42. doi: 10.1016/j.pcad.2014.10.004. Epub 2014 Oct 22. Prog Cardiovasc Dis. 2015. PMID: 25459974 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical